These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27693040)
21. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Chen S; Wang L; Yao B; Liu Q; Guo C Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165 [TBL] [Abstract][Full Text] [Related]
22. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma. Dong J; Teng F; Guo W; Yang J; Ding G; Fu Z Cell Physiol Biochem; 2018; 51(5):2262-2274. PubMed ID: 30537734 [TBL] [Abstract][Full Text] [Related]
23. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma. Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878 [TBL] [Abstract][Full Text] [Related]
24. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma. Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263 [TBL] [Abstract][Full Text] [Related]
25. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692 [TBL] [Abstract][Full Text] [Related]
26. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC. Xu J; Wang Y; Zhang Y; Dang S; He S Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma. Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway. Bai Z; Xia X; Lu J Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177 [TBL] [Abstract][Full Text] [Related]
29. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619 [TBL] [Abstract][Full Text] [Related]
30. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Yan JJ; Zhang YN; Liao JZ; Ke KP; Chang Y; Li PY; Wang M; Lin JS; He XX Oncotarget; 2015 Oct; 6(30):29527-42. PubMed ID: 26336827 [TBL] [Abstract][Full Text] [Related]
31. miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma. Zhai J; Qu S; Li X; Zhong J; Chen X; Qu Z; Wu D Biochem Biophys Res Commun; 2015 Aug; 464(1):161-7. PubMed ID: 26116538 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1. Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017 [TBL] [Abstract][Full Text] [Related]
33. MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A. Quan Y; Song Q; Wang J; Zhao L; Lv J; Gong S Tumour Biol; 2017 Apr; 39(4):1010428317697565. PubMed ID: 28443461 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
35. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p. Wang ZY; Zhu Z; Wang HF; Qin B; Liu J; Yao XH; Li WC; Chen KS J Cell Physiol; 2019 Aug; 234(10):17775-17785. PubMed ID: 30864145 [TBL] [Abstract][Full Text] [Related]
36. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734 [TBL] [Abstract][Full Text] [Related]
37. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma. Wang Q; Yang X; Zhou X; Wu B; Zhu D; Jia W; Chu J; Wang J; Wu J; Kong L Biochem Biophys Res Commun; 2020 Jun; 526(4):889-897. PubMed ID: 32279994 [TBL] [Abstract][Full Text] [Related]
38. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364 [TBL] [Abstract][Full Text] [Related]
39. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis. Chen S; Pu J; Bai J; Yin Y; Wu K; Wang J; Shuai X; Gao J; Tao K; Wang G; Li H J Exp Clin Cancer Res; 2018 Jan; 37(1):3. PubMed ID: 29316949 [TBL] [Abstract][Full Text] [Related]
40. microRNA-622 acts as a tumor suppressor in hepatocellular carcinoma. Song WH; Feng XJ; Gong SJ; Chen JM; Wang SM; Xing DJ; Zhu MH; Zhang SH; Xu AM Cancer Biol Ther; 2015; 16(12):1754-63. PubMed ID: 26467022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]